NextMed is aware of an article published by the Wall Street Journal on 4 March 2023, titled “Startup Offering Ozempic Surges With Controversial Ads, Fake Testimonials”.
NextMed wishes to clarify any misunderstanding caused by the publication and would like to state that NextMed is not affiliated in any way with Helio Logistics, Next Medical, or the URL www.NextMed.com. The companies mentioned in the article focus on weight loss solutions. The content published in the article has no relevance to NextMed’s business and we have taken steps to remedy the incorrect reporting.
We are the only urology service provider with a comprehensive lithotripsy certification from the ACHC, and we adhere to high industry standards and operate with value and integrity across our business. As always, we are committed to providing our integrated urology platform and lithotripsy services of the highest quality to our urologists, facilities and patients. We would like to thank you for your continued trust and support in our company.